SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-06-009168
Filing Date
2006-03-08
Accepted
2006-03-08 17:23:23
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 v037102_10k.htm 10-K 2530955
2 v037102_ex10-20.htm EX-10.20 93557
3 v037102_ex10-21.htm EX-10.21 235011
4 v037102_ex21-1.htm EX-21.1 8647
5 v037102_ex23-1.htm EX-23.1 11406
6 v037102_ex31-1.htm EX-31.1 20688
7 v037102_ex31-2.htm EX-31.2 20544
8 v037102_ex32-1.htm EX-32.1 7168
9 v037102_ex32-2.htm EX-32.2 7624
  Complete submission text file 0001144204-06-009168.txt   2936907
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 06674051
SIC: 2834 Pharmaceutical Preparations